Results 11 to 20 of about 3,618 (129)

Environmentally benign glycosylation of aryl pyranosides and aryl/alkyl furanosides demonstrating the versatility of thermostable CGTase from Thermoanaerobacterium sp. [PDF]

open access: yes, 2014
International audienceAn extensive study on the specificity of transglycosylation and disproportionation of Thermoanaerobacterium sp. cyclodextrin glucosyltranferases against aryl glucopyranosides or furanosides was achieved. While a mixture of maltoside
Chauvin, Anne-Laure   +5 more
core   +3 more sources

Method of identifying inhibitors of glutathione S-transferase (GST) gene expression [PDF]

open access: yes, 1999
Complementary DNA and genomic clones for three variants of GST-.pi. are disclosed. It is demonstrated that certain of these variants are overexpressed in gliomas, thereby indicating an involvement with that form of cancer.
Akande, Olanike   +6 more
core   +1 more source

Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors [PDF]

open access: yes, 2012
N-Myristoyltransferase (NMT) represents a promising drug target for human African trypanosomiasis (HAT), which is caused by the parasitic protozoa Trypanosoma brucei.
Alan H. Fairlamb   +53 more
core   +4 more sources

Chemical proteomics approaches for identifying the cellular targets of natural products. [PDF]

open access: yes, 2016
Covering: 2010 up to 2016. Deconvoluting the mode of action of natural products and drugs remains one of the biggest challenges in chemistry and biology today.
Abegg   +125 more
core   +1 more source

Biocatalytic Friedel-Crafts Reactions [PDF]

open access: yes, 2022
Friedel-Crafts alkylation and acylation reactions are important methodologies in synthetic and industrial chemistry for the construction of aryl-alkyl and aryl-acyl linkages that are ubiquitous in bioactive molecules. Nature also exploits these reactions
Leveson-Gower, Reuben B.   +1 more
core   +1 more source

Nucleosided derived antibiotics to fight microbial drug resistance: New utilities for an established class of drugs? [PDF]

open access: yes, 2016
Novel antibiotics are urgently needed to combat the rise of infections due to drug-resistant microorganisms. Numerous natural nucleosides and their synthetically modified analogues have been reported to have moderate to good antibiotic activity against ...
Ferrari, Valentina   +2 more
core   +1 more source

Creation and evolution of organocatalytic artificial enzymes [PDF]

open access: yes, 2023
Leven is afhankelijk van chemische reacties die allerlei verschillende functies mogelijk maken, en veel van deze reacties moeten worden versneld omdat ze anders extreem traag zouden zijn.
Leveson-Gower, Reuben Boddington
core   +2 more sources

Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019) [PDF]

open access: yes, 2019
The broad interdisciplinary nature of biocatalysis fosters innovation, as different technical fields are interconnected and synergized. A way to depict that innovation is by conducting a survey on patent activities.
Alcántara, Andrés R.   +2 more
core   +3 more sources

Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage X174 lysis protein E, and cationic antibacterial peptides [PDF]

open access: yes, 2016
This review covers recent developments in the inhibition of translocase MraY and related phospho-GlcNAc transferases WecA and TagO, and insight into the inhibition and catalytic mechanism of this class of integral membrane proteins from the structure of ...
Bugg, Tim   +3 more
core   +1 more source

Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities [PDF]

open access: yes, 2016
The HIV-1 ribonuclease H (RNase H) function of the reverse transcriptase (RT) enzyme catalyzes the selective hydrolysis of the RNA strand of the RNA:DNA heteroduplex replication intermediate, and represents a suitable target for drug development.
Carcelli, Mauro   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy